Cargando…
Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience
BACKGROUND: Anaphylaxis occurs in up to 3.5% of hymenoptera stings and can be a life-threatening emergency. Venom immunotherapy (VIT) provides excellent protection from further episodes of anaphylaxis and is well tolerated. In this study the frequency of anaphylactic reactions in pediatric patients...
Autores principales: | Glaeser, Antonia, Müller, Christoph, Bode, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052590/ https://www.ncbi.nlm.nih.gov/pubmed/35488298 http://dx.doi.org/10.1186/s12948-022-00170-3 |
Ejemplares similares
-
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)
por: Stock, Richard, et al.
Publicado: (2020) -
Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush
por: Selcuk, Ali, et al.
Publicado: (2022) -
Clinical Utility of Rush Venom Immunotherapy: Current Status
por: Gruzelle, Vianney, et al.
Publicado: (2020) -
Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019) -
The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
por: Górska, Aleksandra, et al.
Publicado: (2021)